Lynne Marie Sullivan's Net Worth

$8.88 Thousand

Estimate Recalculated Nov 7, 2024 12:13PM EST

Who is Lynne Marie Sullivan?

Lynne Marie Sullivan does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include resTORbio, Inc., Solid Biosciences Inc., Inozyme Pharma, Inc., Unity Biotechnology, Inc., and BiomX Inc..

SEC CIK

Lynne Marie Sullivan's CIK is 0001727640

Past Insider Trading and Trends

2022 was Lynne Marie Sullivan's most active year for acquiring shares with 8 total transactions. Lynne Marie Sullivan's most active month to acquire stocks was the month of May. 2023 was Lynne Marie Sullivan's most active year for disposing of shares, totalling 3 transactions. Lynne Marie Sullivan's most active month to dispose stocks was the month of April. 2023 saw Lynne Marie Sullivan paying a total of $110,800.00 for 162,983 shares, this is the most they've acquired in one year. In 2024 Lynne Marie Sullivan cashed out on 324 shares for a total of $453.60, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

resTORbio, Inc. (ACET) Snapshot price: $1.56

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Jun 3
Form 4
—
0
—
—
0
May 8
Form 3
—
0
—
—
0
No matching records found

Solid Biosciences Inc. (SLDB) Snapshot price: $8.11

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Jun 11
Form 4
—
0
—
—
0
Jun 6
Form 4
—
0
—
—
0
Dec 13
Form 4
—
0
—
—
0
Jun 7
Form 4
—
0
—
—
0
Jun 16
Form 4
—
0
—
—
0
Jun 16
Form 4
—
0
—
—
0
Jun 13
Form 4
—
0
—
—
0
Dec 13
Form 4
—
0
—
—
0
Jul 25
Form 3
—
0
—
—
0
No matching records found

Inozyme Pharma, Inc. (INZY) Snapshot price: $4.98

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Jun 18
Form 4
—
0
—
—
0
Jun 13
Form 4
—
0
—
—
0
Jun 10
Form 4
—
0
—
—
0
Jun 23
Form 4
—
0
—
—
0
Jul 23
Form 3
—
0
—
—
0
No matching records found

Unity Biotechnology, Inc. (UBX) Snapshot price: $1.52

CFO & Head Corp. Dev.

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-0.24%
-136.00
$1.29
-$175.44
55.92K
Nov 4
Form 4
-0.98%
-324.00
$1.40
-$453.60
32.69K
Jun 25
Form 4
—
0
—
—
0
May 11
Form 4
+2.88%
925
$6.89
$6,373.25
33.01K
May 15 - Nov 18
Form 4
+18.06%
50K
—
—
326.79K
Feb 9
Form 4
+12.85%
30.83K
—
—
270.83K
Jun 24
Form 4
∞
240K
—
—
240K
Sep 13
Form 4
—
0
—
—
0
Aug 1
Form 3
—
0
—
—
0
No matching records found

BiomX Inc. (PHGE) Snapshot price: $1.2094

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Mar 1
Form 4
—
0
—
—
0
Mar 29
Form 4
∞
12.5K
$4.00
$50,000.00
12.5K
Jul 28
Form 4
—
0
—
—
0
Mar 30
Form 4
—
0
—
—
0
Mar 25
Form 3
—
0
—
—
0
No matching records found